Rafferty Asset Management
ARRY

Rafferty Asset Management’s Array Biopharma Inc ARRY Stock Holding History

Rafferty Asset Management’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-167,089
Closed -$7.74M – 875
2019
Q2 		$7.74M Sell
167,089
-60,197
-26% -$1.69M 0.14% 91
2019
Q1 		$5.54M Buy
+227,286
New +$4.73M 0.09% 121

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

Rafferty Asset Management's ARRY Position: Q3 2019 in Review

Rafferty Asset Management sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 167,089 shares — an estimated $7.74M sold.

Rafferty Asset Management first reported a position in ARRY in Q1 2019 and held it in 2 quarters. The position peaked at $7.74M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • Rafferty Asset Management reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • Rafferty Asset Management sold 167,089 Array Biopharma Inc shares in Q3 2019, an estimated $7.74M.
  • Rafferty Asset Management first reported a position in Array Biopharma Inc in Q1 2019 and held it in 2 quarters.
  • Rafferty Asset Management's Array Biopharma Inc position peaked at $7.74M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on Rafferty Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.